Revised forecast
Fiscal year ending March 2027 · Full yearPrevious forecast published Announced on 6 August 2026The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
Revenue was revised upward to reflect strong sales of medical systems and semiconductor materials. The operating profit forecast was unchanged from the previous forecast, incorporating expected higher profit in electronics as well as a decline in gross profit and other factors resulting from lower revenue in business innovation.
| Item | Details |
|---|---|
| Net Sales | ¥35,600 100 million → ¥35,900 100 million（0.8%） |
| Operating profit | ¥3,650 100 million → ¥3,650 100 million |
| Profit attributable to owners of the parent | ¥2,800 100 million → ¥2,800 100 million |
| Net income per share | ¥234.19 → ¥234.1（△0.0%） |
| Fiscal Period Covered | Fiscal year ending March 2027 |
| Period Covered | Full year |
| Publication date of previous forecast | Announced on 6 August 2026 |
| Previous-period results | Revenue ¥3,357.0 billion, operating profit ¥350.2 billion, profit before income taxes and other adjustments ¥366.6 billion, net income attributable to owners of the parent ¥276.7 billion, net income attributable to owners of the parent per share ¥2,296.50 |
| Reason for the revision | Revenue was revised upward to reflect strong sales of medical systems and semiconductor materials. The operating profit forecast was unchanged from the previous forecast, incorporating expected higher profit in electronics as well as a decline in gross profit and other factors resulting from lower revenue in business innovation. |
| Dividend forecast revision | No revision |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (2)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Revenue was revised upward to reflect strong sales of medical systems and semiconductor materials. The operating profit forecast was left unchanged from the previous forecast, incorporating expected higher profit in electronics as well as a decline in gross profit resulting from lower revenue in business innovation.